- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness analysis of guidelines for antihypertensive care in Finland ; volume:7 ; number:1 ; day:24 ; month:10 ; year:2007 ; pages:1-14 ; date:12.2007
BMC health services research ; 7, Heft 1 (24.10.2007), 1-14, 12.2007
- Creator
-
Booth, Neill
- Contributor
-
Jula, Antti
Aronen, Pasi
Kaila, Minna
Klaukka, Timo
Kukkonen-Harjula, Katriina
Reunanen, Antti
Rissanen, Pekka
Sintonen, Harri
Mäkelä, Marjukka
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-7-172
- URN
-
urn:nbn:de:1111-2016072121989
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Booth, Neill
- Jula, Antti
- Aronen, Pasi
- Kaila, Minna
- Klaukka, Timo
- Kukkonen-Harjula, Katriina
- Reunanen, Antti
- Rissanen, Pekka
- Sintonen, Harri
- Mäkelä, Marjukka
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates
Cost-effectiveness and algorithmic decision-making
Cost-effectiveness Study of Antihypertensive Drugs in Mumbai, India
Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-Effectiveness of Targeted Reemployment Bonuses
Challenges in synthesising cost-effectiveness estimates